Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Independence Alternative Investments is a private investment management firm, not a life sciences, biotech, pharma, or healthcare operating company. The firm focuses on alternative investment opportunities across real estate, private equity, venture capital, and debt, and syndicates deals for qualified investors. Publicly available company descriptions emphasize capital formation, sponsor relationships, and access to boutique alternative investments rather than drug development, healthcare services, or medical technology. Based on the available evidence, it should be classified as a financial services firm rather than a health-sector company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Independence Investments.